Determination, pharmacokinetics and protein binding of a novel tissue-type plasminogen activator, pamiteplase in human plasma

By Oikawa K.   Watanabe T.   Miyamoto I.   Higuchi S.  

Xenobiotica, Vol. 30, Iss. 10, 2000-10 ,pp. : 993-1003

Informa Healthcare

Access to resources Recommend Favorite

A Method for Defining Binding Sites Involved in Protein–Protein Interactions: Analysis of the Binding of Plasminogen Activator Inhibitor 1 to the Somatomedin Domain of Vitronectin

By Royle G.   Deng G.   Seiffert D.   Loskutoff D.J.  

Analytical Biochemistry, Vol. 296, Iss. 2, 2001-09 ,pp. : 245-253

Elsevier

Access to resources Recommend Favorite

Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction

By Ahmed Waqas   Malik Meera   Saeed Imran   Khan Amina   Sadeque Ahmed   Kaleem Umar   Ahmed Nuzhat   Ajmal Muhammad   Azam Maleeha   Qamar Raheel  

Molecular Biology Reports, Vol. 38, Iss. 4, 2011-04 ,pp. : 2541-2548

Springer Publishing Company

Access to resources Recommend Favorite

Glycated Proteins Modulate Tissue-Plasminogen Activator-Catalyzed Plasminogen Activation

By Bobbink I.W.G.   Tekelenburg W.L.H.   Sixma J.J.   de Boer H.C.   Banga J.D.   de Groot P.G.  

Biochemical and Biophysical Research Communications, Vol. 240, Iss. 3, 1997-11 ,pp. : 595-601

Elsevier

Access to resources Recommend Favorite

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Induces Binding of a 50 kDa Protein on the 3′ Untranslated Region of Urokinase-Type Plasminogen Activator mRNA

By Shimba S.   Hayashi M.   Sone H.   Yonemoto J.   Tezuka M.  

Biochemical and Biophysical Research Communications, Vol. 272, Iss. 2, 2000-06 ,pp. : 441-448

Elsevier

Access to resources Recommend Favorite